Merck (MRK) Q2 Earnings & Sales Beat Estimates, Cuts '24 EPS View

Merck (MRK) reported adjusted earnings of $2.28 per share in second-quarter 2024, beating the Zacks Consensus Estimate of $2.16. In the year-ago period, management incurred an adjusted loss of $2.06. This reported loss was due to a one-time charge of $4.02 per share incurred by the company to acquire Prometheus Biosciences, which was completed in June 2023.Including acquisition and divestiture-related costs, restructuring costs, income and losses from investments in equity securities and certain other items ...